By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Along with several enhancements being considered for its policy on dealing with financial conflicts of interest, the National Institutes of Health is making plans that will shift much of the responsibility for transparency away from the individual and to the institutions they work for, NIH Director Francis Collins said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.